A Potential Complement to Vyvgart in CIDP

研报英文原文证据摘录

A Potential Complement to Vyvgart in CIDP

ERPERFORM: 2.04% UNDERPERFORM: 0.00%

The Distribution of Ratings is required by FINRA rules; however, WS' stock ratings of Outperform, Neutral, and Underperform most

closely conform to Buy, Hold, and Sell, respectively. Please note, however, the definitions are not the same as WS' stock ratings are

on a relative basis.

The analysts responsible for preparing research reports do not receive compensation based on specific investment banking activity.

The analysts receive compensation that is based upon various factors including WS' total revenues, a portion of which are generated

by WS' investment banking activities.

Company Specific Disclosures

This information is subject to change at any time.

This research is provided for educational and informational purposes only and is not intended to be relied upon as a forecast,

research, or investment advice, and is not a recommendation, offer, or solicitation to buy or sell any securities or to adopt any

investment strategy. Investing involves risk, including the risk of loss of principal. Your investments may decline in value due to both

real and perceived general market, economic, and industry conditions. Diversification does not ensure profits or protect against loss.

This research was prepared without regard to specific investment objectives, strategies, tax status, investment horizon, financial

situation or needs of any investor. Wedbush Securities, Inc. (“WSI”) encourages recipients of this report to read all relevant offering

documents (e.g., prospectus) pertaining to any investment concerned, including without limitation, information relevant to its

investment objectives, risks, and costs before making an investment decision and when deemed necessary, to seek the advice of a